Recent advances in molecular biomarkers for diabetes mellitus: a systematic review

References

• Akinkuolie, A.O., et al., 2015. Novel protein glycan side-chain biomarker and risk of incident type 2 diabetes. Arteriosclerosis, thrombosis, and vascular biology, 35, 1544–1550.
   PubMed Web of Science ®Google Scholar
• Al-Kafaji, G., et al., 2016. Circulating endothelium-enriched microRNA-126 as a potential biomarker for coronary artery disease in type 2 diabetes mellitus patients. Biomarkers, 1–11. doi: http://dx.doi.org/10.1080/1354750X.2016.1204004.
   PubMed Web of Science ®Google Scholar
• Al-Kafaji, G., et al., 2015. Peripheral blood microRNA-15a is a potential biomarker for type 2 diabetes mellitus and pre-diabetes. Molecular medicine reports, 12, 7485–7490.
   PubMed Web of Science ®Google Scholar
• Anand, K., et al., 2016. Secreted Frizzled-Related Protein 4 (SFRP4): a novel biomarker of β-cell dysfunction and insulin resistance in individuals with prediabetes and type 2 diabetes. Diabetes care, 39, e147–e148.
   PubMed Web of Science ®Google Scholar
• Baker Idi Heart and Diabetes Institute, Diabetes Australia & Juvenile Diabetes Research Foundation, 2012. Diabetes: the silent pandemic and its impact on Australia.: D. Australia.
   Google Scholar
• Bishnoi, S., Goyal, R.N., and Shim, Y., 2014. A novel nanogold–single wall carbon nanotube modified sensor for the electrochemical determination of 8-hydroxyguanine, a diabetes risk biomarker. Bioelectrochemistry, 99, 24–29.
   PubMed Web of Science ®Google Scholar
• Blennow, K., et al., 2015. Clinical utility of cerebrospinal fluid biomarkers in the diagnosis of early Alzheimer's disease. Alzheimers dement, 11, 58–69.
   PubMed Web of Science ®Google Scholar
• Bonci, D., et al., 2016. A microRNA code for prostate cancer metastasis. Oncogene, 35, 1180–1192.
   PubMed Web of Science ®Google Scholar
• Borges, C.R., et al., 2011. Building multidimensional biomarker views of type 2 diabetes on the basis of protein microheterogeneity. Clinical chemistry, 57, 719–728.
   PubMed Web of Science ®Google Scholar
• Bourne, R.R.A., et al., 2013. Causes of vision loss worldwide, 1990–2010: a systematic analysis. The lancet global health, 1, e339–e349.
   PubMed Web of Science ®Google Scholar
• Caveney, E.J. and Cohen, O.J., 2011. Diabetes and biomarkers. Journal of diabetes science and technology, 5, 192–197.
   PubMedGoogle Scholar
• Cooper, A.J.M., et al., 2015. The association between a biomarker score for fruit and vegetable intake and incident type 2 diabetes: the EPIC-Norfolk study. European journal of clinical nutrition, 69, 449–454.
   PubMed Web of Science ®Google Scholar
• Denk, J., et al., 2015. MicroRNA profiling of CSF reveals potential biomarkers to detect Alzheimer′s disease. PLoS one, 10, e0126423.
   PubMed Web of Science ®Google Scholar
• Erener, S., et al., 2013. Circulating miR-375 as a biomarker of β-cell death and diabetes in mice. Endocrinology, 154, 603–608.
   PubMed Web of Science ®Google Scholar
• Fda-Nih Biomarker Working Group, 2016. BEST (Biomarkers, EndpointS, and other Tools) Resource. Silver Spring (MD): Food and Drug Administration (US). Copublished by National Institutes of Health (US), Bethesda (MD).
   Google Scholar
• Ghosh, C., et al., 2015. Oxygen-18 isotope of breath CO2 linking to erythrocytes carbonic anhydrase activity: a biomarker for pre-diabetes and type 2 diabetes. Scientific reports, 5, 8137.
   PubMed Web of Science ®Google Scholar
• Ghosh, P., et al., 2013. A specific and sensitive assay for blood levels of glycated CD59: a novel biomarker for diabetes. American journal of hematology, 88, 670–676.
   PubMed Web of Science ®Google Scholar
• Haseda, F., et al., 2016. Antibody to CMRF35-like molecule 2, CD300e a novel biomarker detected in patients with fulminant type 1 diabetes. PLoS one, 11, e0160576.
   PubMed Web of Science ®Google Scholar
• Heraclides, A., et al., 2013. The pro-inflammatory biomarker soluble urokinase plasminogen activator receptor (suPAR) is associated with incident type 2 diabetes among overweight but not obese individuals with impaired glucose regulation: effect modification by smoking and body weight status. Diabetologia, 56, 1542–1546.
   PubMed Web of Science ®Google Scholar
• Il'yasova, D., et al., 2012. Urinary F2-isoprostanes as a biomarker of reduced risk of type 2 diabetes. Diabetes care, 35, 173–174.
   PubMed Web of Science ®Google Scholar
• International Diabetes Federation, 2015. International Diabetes Federation Diabetes Atlas. Brussels, Belgium: I.D. Federation.
   Google Scholar
• Knebel, B., et al., 2016. Untargeted mass spectrometric approach in metabolic healthy offspring of patients with type 2 diabetes reveals medium-chain acylcarnitine as potential biomarker for lipid induced glucose intolerance (LGIT). Archives of physiology and biochemistry, 122, 266–280.
   PubMed Web of Science ®Google Scholar
• Kosaka, N., Iguchi, H., and Ochiya, T., 2010. Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis. Cancer science, 101, 2087–2092.
   PubMed Web of Science ®Google Scholar
• Kroh, E.M., et al., 2010. Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR). Methods, 50, 298–301.
   PubMed Web of Science ®Google Scholar
• Liu, Y., et al., 2014. The role of circulating MicroRNA-126 (miR-126): a novel biomarker for screening prediabetes and newly diagnosed type 2 diabetes mellitus. International journal of molecular sciences, 15, 10567–10577.
   PubMed Web of Science ®Google Scholar
• Liu, Z., et al., 2012. Prevention of Type 1 diabetes in the rat with an allele-specific anti-T-cell receptor antibody: Vβ13 as a therapeutic target and biomarker. Diabetes, 61, 1160–1168.
   PubMed Web of Science ®Google Scholar
• Luo, M., et al., 2015. Platelet-derived miR-103b as a novel biomarker for the early diagnosis of type 2 diabetes. Acta diabetologica 52, 943–949.
   PubMed Web of Science ®Google Scholar
• Ma, W.Y., et al., 2014. Plasma apelin: a novel biomarker for predicting diabetes. Clinica chimica acta 435, 18–23.
   PubMed Web of Science ®Google Scholar
• Min, P.K. and Chan, S.Y. 2015. The biology of circulating microRNAs in cardiovascular disease. European journal clinical investigation 45, 860–874.
   PubMed Web of Science ®Google Scholar
• Moher, D., et al. The Prisma Group, 2009. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS medicine, 6, e1000097.
   PubMed Web of Science ®Google Scholar
• Mraz, M., et al. 2009. MicroRNA isolation and stability in stored RNA samples. Biochemical and biophysical research communications, 390, 1–4.
   PubMed Web of Science ®Google Scholar
• Olsen, J.A., et al., 2016. Circulating differentially methylated amylin DNA as a biomarker of β-cell loss in type 1 diabetes. PLoS one 11, e0152662.
   PubMed Web of Science ®Google Scholar
• Strimbu, K. and Tavel, J.A. 2010. What are biomarkers? Current opinion in HIV and AIDS, 5, 463–466.
   PubMed Web of Science ®Google Scholar
• Takada, T., et al., 2013. Serum monomeric α2-macroglobulin as a clinical biomarker in diabetes. Atherosclerosis, 228, 270–276.
   PubMed Web of Science ®Google Scholar
• Thanabalasingham, G., et al., 2011. A large multi-centre European study validates high-sensitivity C-reactive protein (hsCRP) as a clinical biomarker for the diagnosis of diabetes subtypes. Diabetologia, 54, 2801–2810.
   PubMed Web of Science ®Google Scholar
• The Emerging Risk Factors Collaboration, 2010. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. The lancet, 375, 2215–2222.
   PubMed Web of Science ®Google Scholar
• Varvel, S.A., et al., 2014. Comprehensive biomarker testing of glycemia, insulin resistance, and beta cell function has greater sensitivity to detect diabetes risk than fasting glucose and hba1c and is associated with improved glycemic control in clinical practice. Journal of cardiovascular translational research, 7, 597–606.
   PubMed Web of Science ®Google Scholar
• Wang, S., et al., 2014. Assessment of serum arginase I as a type 2 diabetes mellitus diagnosis biomarker in patients. Experimental and therapeutic medicine, 8, 585–590.
   PubMed Web of Science ®Google Scholar
• Wang, T.J., et al., (2013). 2-Aminoadipic acid is a biomarker for diabetes risk. The journal of clinical investigation, 123, 4309–4317.
   PubMed Web of Science ®Google Scholar
• World Health Organisation, 2016. Global report on diabetes. France: W.H. Organisation.
   Google Scholar
• Yang, Z., et al., 2014. Serum miR-23a, a potential biomarker for diagnosis of pre-diabetes and type 2 diabetes. Acta diabetologica, 51, 823–831.
   PubMed Web of Science ®Google Scholar
• Yau, J.W.Y., et al., 2012. Global prevalence and major risk factors of diabetic retinopathy. Diabetes care, 35, 556–564.
   PubMed Web of Science ®Google Scholar
• Yi, M., et al., 2015. Betatrophin acts as a diagnostic biomarker in type 2 diabetes mellitus and is negatively associated with HDL-cholesterol. International journal of endocrinology, 2015, 7.
   Web of Science ®Google Scholar
• Zhang, B., et al., 2014. A plasmonic chip for biomarker discovery and diagnosis of type 1 diabetes. Nature medicine, 20, 948–953.
   PubMed Web of Science ®Google Scholar
• Zhang, T., et al., 2015. Circulating miR-126 is a potential biomarker to predict the onset of type 2 diabetes mellitus in susceptible individuals. Biochemical and biophysical research communications, 463, 60–63.
   PubMed Web of Science ®Google Scholar
• Zhang, T., et al., 2013. Plasma miR-126 is a potential biomarker for early prediction of type 2 diabetes mellitus in susceptible individuals. BioMed research international, 2013, 6.
   Google Scholar